Europe Women’s Digital Health Market

Table of Contents

1. PREFACE
1.1. Scope of the Report
1.2. Research Methodology
1.3. Key Questions Answered
1.4. Chapter Outlines

2. EXECUTIVE SUMMARY

3. INTRODUCTION
3.1. Chapter Overview
3.2. Introduction to Digital Health
3.3. Women’s Digital Health
3.4. Importance of Women’s Digital Health
3.5. Challenges Related to Women’s Digital Health
3.6. Future Perspectives

4. MARKET LANDSCAPE
4.1. Chapter Overview
4.2 Europe Women’s Digital Health: Product Pipeline
4.2.1 Analysis by Type of Solution
4.2.2 Analysis by Current Status of Development
4.2.3 Analysis of Women’s Digital Health Applications by Ratings
4.2.4 Analysis by Therapeutic Application Area
4.2.5 Analysis by Usage Period with respect to Pregnancy
4.2.6 Analysis by Purpose
4.2.7 Analysis by End-Users
4.2.8 Analysis by Therapeutic Application Area and Type of Solution

4.3 Women’s Digital Health: Europe Based Women’s Digital Health Solutions Developer Landscape
4.3.1 Analysis by Year of Establishment
4.3.2 Analysis by Company Size
4.3.3 Analysis by Region of Headquarters
4.3.4 Analysis by Company Size and Region of Headquarters
4.3.5 Analysis by Location of Headquarters
4.3.6 Leading Players: Analysis by Number of Solutions
4.3.7 Regional Landscape: Analysis by Type of Solution

5. WOMEN’S DIGITAL HEALTH DEVELOPERS IN EUROPE: COMPANY PROFILES
5.1. Chapter Overview
5.2. Ava Women
5.2.1. Company Overview
5.2.2. Product / Service Portfolio
5.2.3. Women’s Digital Health Product / Service(s) Offered
5.2.4. Recent Developments and Future Outlook

5.3. Braster
5.3.1. Company Overview
5.3.2. Product / Service Portfolio
5.3.3. Women’s Digital Health Product / Service(s) Offered
5.3.4. Recent Developments and Future Outlook

5.4. Clue By Biowink
5.4.1. Company Overview
5.4.2. Product / Service Portfolio
5.4.3. Women’s Digital Health Product / Service(s) Offered
5.4.4. Recent Developments and Future Outlook

5.5. Elvie
5.5.1. Company Overview
5.5.2. Product / Service Portfolio
5.5.3. Women’s Digital Health Product / Service(s) Offered
5.5.4. Recent Developments and Future Outlook

5.6. Natural Cycles
5.6.1. Company Overview
5.6.2. Product / Service Portfolio
5.6.3. Women’s Digital Health Product / Service(s) Offered
5.6.4. Recent Developments and Future Outlook

6. FUNDING AND INVESTMENT ANALYSIS
6.1. Chapter Overview
6.2. Types of Funding
6.3. Women’s Digital Health: Funding and Investment Analysis
6.3.1. Analysis by Year, Type of Funding and Amount Invested
6.3.2. Analysis by Year of Investment
6.3.3. Analysis by Amount Invested
6.3.4. Analysis by Type of Funding
6.3.5. Analysis by Type of Funding and Amount Invested
6.3.6. Most Active Players: Analysis by Number of Funding Instances
6.3.7. Most Active Players: Analysis by Amount Raised
6.3.8. Key Investors: Analysis by Number of Instances
6.3.9. Analysis by Type of Solution
6.3.10. Analysis by Type of Solution and Amount Invested
6.3.11. Analysis by Therapeutic Application Area
6.3.12. Analysis by Geography
6.3.13. Analysis by Year, Therapeutic Application Area and Amount Invested
6.3.14. Summary of Investments

7. PARTNERSHIPS AND COLLABORATIONS
7.1. Chapter Overview
7.2 Partnership Models
7.3. List of Partnerships and Collaborations
7.3.1. Analysis by Year of Partnership
7.3.2. Analysis by Type of Partnership
7.3.3. Analysis by Product / Solution
7.3.4. Analysis by Type of Partner
7.3.5. Analysis by Year of Partnership and Type of Partner
7.3.6. Analysis by Type of Partnership and Product / Solution
7.3.7. Most Active Players: Analysis by Number of Partnerships
7.3.8. Leading Players: Analysis by Type of Partnership
7.3.9. Regional Analysis
7.3.10. Intercontinental and Intracontinental Agreements

8. STARTUP HEALTH INDEXING
8.1. Chapter Overview
8.2. Scope and Methodology
8.3. Benchmarking of Start-ups
8.3.1. Analysis by Type of Product / Solution
8.3.2. Analysis by Therapeutic Application Area
8.3.3. Analysis by Usage Period with respect to Pregnancy
8.3.4 Analysis by Partnership Activity
8.3.5. Analysis by Funding Activity
8.3.6. Analysis by Progression of Funding
8.3.7. Analysis by Type of Funding
8.3.8. Analysis by Location of Headquarters
8.3.9. Start-up Health Indexing: Roots Analysis Perspective

9. GLOBAL EVENTS ANALYSIS
9.1. Chapter Overview
9.2. Scope and Methodology
9.3. Global Events related to Women’s Digital Health
9.3.1. Analysis by Year of Event
9.3.2. Analysis by Event Platform
9.3.3. Analysis by Type of Event
9.3.4. Analysis by Geography
9.3.5. Word Cloud: Evolutionary Trends in Event Agenda / Key Focus Areas
9.3.6. Most Active Event Organizers: Analysis by Number of Events
9.3.7. Most Active Participants: Analysis by Number of Events
9.3.8. Analysis by Seniority Level of Participants
9.3.9. Most Active Speakers: Analysis by Number of Events
9.3.10. Geographical Mapping of Upcoming Events

10. SWOT ANALYSIS
10.1. Chapter Overview
10.2. Women’s Digital Health: SWOT Analysis
10.2.1. Comparison of SWOT Factors
10.2.1.1. Strengths
10.2.1.2. Weaknesses
10.2.1.3. Opportunities
10.2.1.4. Threats

11. PRODUCT DEVELOPMENT AND SUCCESS ANALYSIS
11.1. Chapter Overview
11.2. Methodology
11.3. Product Development and Success Analysis of Women’s Digital Health Applications
11.3.1. Competitiveness Analysis of Top Applications

11.3.2. Top Five Applications Focused on Women’s Digital Health
11.3.2.1. Flo
11.3.2.2. Clue Period Tracker
11.3.2.3. Ovulation & Period Tracker
11.3.2.4. NC° Birth Control
11.3.2.5. Maya

11.3.3. Average Score Required for the Success of Applications

11.4. Product Development and Success Analysis of Women’s Digital Health Devices
11.4.1. Competitiveness Analysis of Top Devices
11.4.2. Top 5 Devices Focused on Women’s Digital Health
11.4.2.1. Elvie Trainer
11.4.2.2. Ivy
11.4.2.3. breathe ilo
11.4.2.4. Roo
11.4.2.5. Embr Wave 2: Thermal Wellness

11.4.3. Average Score Required for the Success of Devices

11.5. Women’s Digital Health: Unmet Needs
11.5.1. Analysis by Therapeutic Application Areas and Type of Solutions
11.5.2. Analysis by Type of Solutions and Usage Period of Solution with respect to Pregnancy
11.5.3. Women’s Digital Health Solutions: Estimated Average Number of Users Across Various Therapeutic Application Areas

12. MARKET FORECAST AND OPPORTUNITY ANALYSIS
12.1. Chapter Overview
12.2. Forecast Methodology and Key Assumptions
12.3. Overall Europe Women’s Digital Health Market, 2024-2035
12.3.1. Europe Women’s Digital Health Market, 2024-2035: Distribution by Type of Solution
12.3.1.1. Europe Women’s Digital Health Market for Applications / Software, 2024-2035
12.3.1.2. Europe Women’s Digital Health Market for Devices, 2024-2035
12.3.1.3. Europe Women’s Digital Health Market for Services, 2024-2035

12.3.2. Europe Women’s Digital Health Market: Distribution by Therapeutic Application Area, 2024 and 2035

12.3.3. Europe Women’s Digital Health Market: Distribution by Countries, 2024 and 2035
12.3.3.1. Women’s Digital Health Market in Germany, 2024-2035
12.3.3.2. Women’s Digital Health Market in UK, 2024-2035
12.3.3.3. Women’s Digital Health Market in France, 2024-2035
12.3.3.4. Women’s Digital Health Services Market in Russia, 2024-2035
12.3.3.5. Women’s Digital Health Services Market in Italy, 2024-2035
12.3.3.6. Women’s Digital Health Services Market in Rest of the Europe, 2024-2035

12.4. Europe Women’s Digital Health Market for Applications / Software, 2024-2035
12.4.1. Europe Women’s Digital Health Market for Applications / Software, 2024-2035: Distribution by Therapeutic Application Area
12.4.1.1. Europe Women’s Digital Health Applications / Software Market for Fetal Health, 2024-2035
12.4.1.2. Europe Women’s Digital Health Applications / Software Market for General Wellness, 2024-2035
12.4.1.3. Europe Women’s Digital Health Applications / Software Market for Menstrual Cycle, 2024-2035
12.4.1.4. Europe Women’s Digital Health Applications / Software Market for Pelvic Care, 2024-2035
12.4.1.5. Europe Women’s Digital Health Applications / Software Market for Reproductive Health / Fertility, 2024-2035

12.4.2. Europe Women’s Digital Health Market for Applications / Software, 2024-2035: Distribution by Countries
12.4.2.1. Women’s Digital Health Applications / Software Market in Germany, 2024-2035
12.4.2.2. Women’s Digital Health Applications / Software Market in UK, 2024-2035
12.4.2.3. Women’s Digital Health Applications / Software Market in France, 2024-2035
12.4.2.4. Women’s Digital Health Applications / Software Market in Russia, 2024-2035
12.4.2.5. Women’s Digital Health Applications / Software Market in Italy, 2024-2035
12.4.2.6. Women’s Digital Health Applications / Software Market in Rest of Europe, 2024-2035

12.5. Europe Women’s Digital Devices, 2024-2035
12.5.1. Europe Women’s Digital Health Market for Devices, 2024-2035: Distribution by Therapeutic Application Area
12.5.1.1. Europe Women’s Digital Health Device Market for Fetal Health, 2024-2035
12.5.1.2. Europe Women’s Digital Health Device Market for General Wellness, 2024-2035
12.5.1.3. Europe Women’s Digital Health Device Market for Menstrual Cycle, 2024-2035
12.5.1.4. Europe Women’s Digital Health Device Market for Pelvic Care, 2024-2035
12.5.1.5. Europe Women’s Digital Health Device Market for Reproductive Health / Fertility, 2024-2035

12.5.2. Europe Women’s Digital Health Market for Applications / Software, 2024-2035: Distribution by Countries
12.5.2.1. Women’s Digital Health Device Market in Germany, 2024-2035
12.5.2.2. Women’s Digital Health Device Market in UK, 2024-2035
12.5.2.3. Women’s Digital Health Device Market in France, 2024-2035
12.5.2.4. Women’s Digital Health Device Market in Russia, 2024-2035
12.5.2.5. Women’s Digital Health Device Market in Italy, 2024-2035
12.5.2.6. Women’s Digital Health Device Market in Rest of the Europe, 2024-2035

12.6. Europe Women’s Digital Health Market for Services, 2024-2035
12.6.1. Europe Women’s Digital Health Market for Services, 2024-2035: Distribution by Therapeutic Application Area
12.6.1.1. Europe Women’s Digital Health Services Market for Fetal Health, 2024-2035
12.6.1.2. Europe Women’s Digital Health Services Market for General Wellness, 2024-2035
12.6.1.3. Europe Women’s Digital Health Services Market for Menstrual Cycle, 2024-2035
12.6.1.4. Europe Women’s Digital Health Services Market for Pelvic Care, 2024-2035
12.6.1.5. Europe Women’s Digital Health Services Market for Reproductive Health / Fertility, 2024-2035

12.6.2. Europe Women’s Digital Health Market for Services, 2024-2035: Distribution by Countries
12.6.2.1. Women’s Digital Health Services Market in Germany, 2024-2035
12.6.2.2. Women’s Digital Health Services Market in UK, 2024-2035
12.6.2.3. Women’s Digital Health Services Market in France, 2024-2035
12.6.2.4. Women’s Digital Health Services Market in Russia, 2024-2035
12.6.2.5. Women’s Digital Health Services Market in Italy, 2024-2035
12.5.6.6. Women’s Digital Health Services Market in Rest of the Europe, 2024-2035

13. ROLE OF DIGITALIZATION IN WOMEN’S LIFE
13.1. Chapter Overview
13.2. Evolution of Digital Solutions for Women during COVID-19 Pandemic
13.2.1. Learning New Skills

13.3. Opportunities in Professional and Personal Life
13.3.1. Small Scale Online Businesses
13.3.2. Demand for Online Financial Products

13.4. Existing Digital Gender Gap
13.4.1. Impact of AI on Digital Gender Gap

13.5. Skills Shortfall
13.6. Strengthening Ways for Digital Adoption among Women

14. DIGITAL TRENDS: RESHAPING THE FUTURE OF HEALTHCARE
14.1. Chapter Overview
14.2. Artificial Intelligence
14.2.1. Role of Artificial Intelligence in Healthcare
14.2.2. Digital Adoption: Companies employing Artificial Intelligence in Healthcare Solutions

14.3. Machine Learning
14.3.1. Role of Machine Learning in Healthcare
14.3.2. Digital Adoption: Companies employing Machine Learning in Healthcare

14.4. Deep Learning
14.4.1. Role of Deep Learning in Healthcare

14.5. Metaverse
14.5.1. Role of Metaverse in Healthcare

14.6. Conclusion

15. CONCLUSION

16. EXECUTIVE INSIGHTS

17. APPENDIX 1: TABULATED DATA

18. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS